Merck & Co., Inc. is 210.8x more valuable than Harrow, Inc. by market capitalization ($293.16 B vs $1.39 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HROW | MRK |
|---|---|---|
| Market cap | $1.39 B | $293.16 B |
| US-listed rank | #2389 | #44 |
| Revenue (latest FY) | $272.30M | $65.01B |
| Net income (latest FY) | -$5.14M | $18.25B |
| Net margin | -1.9% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 849 | 996 |
Merck & Co., Inc. is 210.8x more valuable than Harrow, Inc. by market capitalization ($293.16 B vs $1.39 B).
In their latest fiscal years, Harrow, Inc. reported $272.30M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Harrow, Inc. and Merck & Co., Inc., or browse the full rankings.